IS5540A - Tríazóló-pýradazín afleiður sem tenglar fyrir GABA viðtaka - Google Patents

Tríazóló-pýradazín afleiður sem tenglar fyrir GABA viðtaka

Info

Publication number
IS5540A
IS5540A IS5540A IS5540A IS5540A IS 5540 A IS5540 A IS 5540A IS 5540 A IS5540 A IS 5540A IS 5540 A IS5540 A IS 5540A IS 5540 A IS5540 A IS 5540A
Authority
IS
Iceland
Prior art keywords
pyradazine
triazolo
derivatives
link
gaba receptors
Prior art date
Application number
IS5540A
Other languages
English (en)
Inventor
Robert Carling William
Luis Castro Pineiro Jose
James Collins Ian
Richard Guiblin Alexander
Harrison Timothy
Madin Andrew
William Moore Kevin
Geoffrey Neil Russel Michael
Scott Gayle
Joseph Street Leslie
Original Assignee
Merck Sharp & Dohme Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9801233.9A external-priority patent/GB9801233D0/en
Priority claimed from GBGB9821517.1A external-priority patent/GB9821517D0/en
Application filed by Merck Sharp & Dohme Limited filed Critical Merck Sharp & Dohme Limited
Publication of IS5540A publication Critical patent/IS5540A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS5540A 1998-01-21 2000-06-16 Tríazóló-pýradazín afleiður sem tenglar fyrir GABA viðtaka IS5540A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9801233.9A GB9801233D0 (en) 1998-01-21 1998-01-21 Therapeutic agents
GBGB9821517.1A GB9821517D0 (en) 1998-10-02 1998-10-02 Therapeutic agents
PCT/GB1999/000103 WO1999037644A1 (en) 1998-01-21 1999-01-13 Triazolo-pyridazine derivatives as ligands for gaba receptors

Publications (1)

Publication Number Publication Date
IS5540A true IS5540A (is) 2000-06-16

Family

ID=26312988

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5540A IS5540A (is) 1998-01-21 2000-06-16 Tríazóló-pýradazín afleiður sem tenglar fyrir GABA viðtaka

Country Status (24)

Country Link
US (2) US6579875B1 (is)
EP (1) EP1049696A1 (is)
JP (1) JP2002501066A (is)
KR (1) KR20010034257A (is)
CN (1) CN1110498C (is)
AU (1) AU748737B2 (is)
BG (1) BG104671A (is)
BR (1) BR9906905A (is)
CA (1) CA2315763A1 (is)
CZ (1) CZ290883B6 (is)
EA (1) EA002755B1 (is)
EE (1) EE200000430A (is)
GE (1) GEP20032868B (is)
HR (1) HRP20000492A2 (is)
HU (1) HUP0100575A3 (is)
IL (1) IL136442A0 (is)
IS (1) IS5540A (is)
MX (1) MXPA00007135A (is)
NO (1) NO315516B1 (is)
NZ (1) NZ504870A (is)
PL (1) PL341652A1 (is)
SK (1) SK10922000A3 (is)
WO (1) WO1999037644A1 (is)
YU (1) YU43800A (is)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU748737B2 (en) * 1998-01-21 2002-06-13 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9929685D0 (en) * 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0017543D0 (en) 2000-07-17 2000-09-06 Merck Sharp & Dohme Therapeutic agents
JP4867350B2 (ja) * 2003-12-19 2012-02-01 宇部興産株式会社 4−置換−4−シアノテトラヒドロピラン化合物の製法
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
HUE030390T2 (en) * 2005-12-21 2017-05-29 Janssen Pharmaceutica Nv Triazolopyridazines as tyrosine kinase modulators
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2123619A1 (de) 2008-05-20 2009-11-25 Bayer Schering Pharma AG Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung
ES2451542T3 (es) * 2008-08-29 2014-03-27 Concert Pharmaceuticals Inc. Derivados de triazolo-piridazina sustituidos
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8501738B2 (en) 2009-06-23 2013-08-06 Concert Pharmaceuticals, Inc. Substituted triazolo-pyridazine derivatives
PT2464645T (pt) * 2009-07-27 2017-10-11 Gilead Sciences Inc Compostos heterocíclicos fusionados como moduladores do canal de iões
EP3753410A3 (en) 2010-09-28 2021-04-28 The Regents Of The University Of California Combinations comprising gaba agonists in treatment of hyperglycemia
AU2012253653A1 (en) 2011-05-10 2013-05-02 Gilead Sciences, Inc. Fused heterocyclic compounds as sodium channel modulators
TWI622583B (zh) 2011-07-01 2018-05-01 基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (is) 2011-07-01 2018-04-28
GB201321745D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
CN109069578A (zh) 2016-02-29 2018-12-21 达纳-法伯癌症研究所股份有限公司 用于治疗感染的钉合的细胞内靶向抗微生物肽
CN107344936B (zh) * 2016-05-06 2022-06-03 上海赛默罗生物科技有限公司 三唑哒嗪类衍生物、其制备方法、药物组合物和用途
JP7305614B2 (ja) 2017-07-19 2023-07-10 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド 抗生物質耐性細菌感染症の処置のための安定化抗菌ペプチド

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230705A (en) 1976-09-22 1980-10-28 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
CA1080712A (en) 1976-09-22 1980-07-01 Jay D. Albright Hypotensive agents
US4112095A (en) * 1976-10-07 1978-09-05 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
PH12424A (en) 1976-10-26 1979-02-15 American Cyanamid Co Method of treating anxiety in mammals
US4260755A (en) 1979-10-31 1981-04-07 American Cyanamid Company Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines
US4260756A (en) 1979-11-15 1981-04-07 American Cyanamid Company 6- And 8-heteroaryl-1,2,4-triazolo[4,3-b]pyridazines
PH21834A (en) 1982-01-18 1988-03-17 Lepetit Spa New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
US4654343A (en) * 1985-10-31 1987-03-31 American Cyanamid Company N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
AU723098B2 (en) * 1996-07-25 2000-08-17 Merck Sharp & Dohme Limited Substituted triazolo-pyridazine derivatives as ligands for GABA receptors
AU748737B2 (en) 1998-01-21 2002-06-13 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors

Also Published As

Publication number Publication date
EE200000430A (et) 2001-12-17
CZ20002691A3 (cs) 2000-12-13
US6579875B1 (en) 2003-06-17
AU2065799A (en) 1999-08-09
EA200000783A1 (ru) 2000-12-25
IL136442A0 (en) 2001-06-14
GEP20032868B (en) 2003-01-27
CA2315763A1 (en) 1999-07-29
SK10922000A3 (sk) 2001-03-12
US6828322B2 (en) 2004-12-07
HUP0100575A2 (hu) 2001-09-28
NO20003730D0 (no) 2000-07-20
BR9906905A (pt) 2000-10-10
HRP20000492A2 (en) 2000-12-31
EP1049696A1 (en) 2000-11-08
NO315516B1 (no) 2003-09-15
NZ504870A (en) 2002-11-26
PL341652A1 (en) 2001-04-23
YU43800A (sh) 2002-12-10
US20040063714A1 (en) 2004-04-01
JP2002501066A (ja) 2002-01-15
BG104671A (en) 2001-05-31
HUP0100575A3 (en) 2003-03-28
NO20003730L (no) 2000-09-20
MXPA00007135A (es) 2002-11-07
CN1288465A (zh) 2001-03-21
EA002755B1 (ru) 2002-08-29
CN1110498C (zh) 2003-06-04
AU748737B2 (en) 2002-06-13
WO1999037644A1 (en) 1999-07-29
KR20010034257A (ko) 2001-04-25
CZ290883B6 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
IL156294A0 (en) Benzimidazole and pyridylimidazole derivatives as ligands to gaba receptors
DE69930562D1 (de) Kettenrad für Fahrrad
IS5581A (is) Ný efnasambönd og notkun þeirra sem jákvæðir beinar AMPA-viðtaka
DE69936659D1 (de) Schweisshemmende zusammensetzungen
IS5690A (is) Ísóþíazól afleiður gagnlegar sem miðlar gegn krabbameini
GB0027773D0 (en) Gaba B receptors
IS5818A (is) Alkýnýl-setnar kínólín-2-ón afleiður gagnlegar sem miðlar gegn krabbameini
DE69926207D1 (de) Fahrradrad
DE59902065D1 (de) Drehschnellverschluss zum miteinander verbinden mehrerer bauteile
NO20010193L (no) Tiobenzimidazol-derivater
NO990187D0 (no) Benzosulfon-derivater
DE69926206D1 (de) Fahrradrad
ATE259810T1 (de) Phenyl-xanthinderivate
NO20003730L (no) Triazolo-pyridazinderivater som ligander for GABA reseptorer
DE69911467D1 (de) Kette
DE59905746D1 (de) Ummantelung
IS5382A (is) Setin 4-oxo-napthyridine-3-karboxamíð sem tengistGABA viðtökum í heila
IS6290A (is) Sameinuð pirrolecarboxamíð; GABA viðtakar í heila
NO20011512D0 (no) 2-Fenylpyran-4-on derivater
IS5746A (is) Tetrahýdrókínólín afleiður sem glysín mótlyf
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
FI990228L (fi) Paperinvalmistuksen lisäainekoostumus
ITTO990786A0 (it) Motocicletta
FI990227L (fi) Paperinvalmistuksen lisäaine
DE69927724D1 (de) Strammvorrichtung